7 Results for "

rat DHODH

" in MedChemExpress (MCE) Product Catalog:
Products (7)

7 Results for "rat DHODH" in MCE Product Catalog:

Cat. No.: HY-135678
CAS No.: 1364791-93-4
Purity:  99.81%
DHODH-IN-14 (Compound 7l) is a hydroxyfurazan analog of A771726. DHODH-IN-14 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 0.49 μM for rat liver DHODH. DHODH-IN-14 can be used for rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-135675
CAS No.: 1263303-95-2
Purity:  99.69%
DHODH-IN-11 (Compound 14b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03 .
loading...
    loading...
Cat. No.: HY-RS03736
Research Areas:  

Others

Dhodh Rat Pre-designed siRNA Set A contains three designed siRNAs for Dhodh gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-135677
CAS No.: 1364791-86-5
DHODH-IN-13 (Compound 7a) is a hydroxyfurazan analog of A771726. DHODH-IN-13 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 4.3 μM for rat liver DHODH. DHODH-IN-13 can be used for rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-135679
CAS No.: 1364791-88-7
DHODH-IN-15 (Compound 7b) is a hydroxyfurazan analog of A771726. DHODH-IN-15 is a dihydroorotate dehydrogenase (DHODH) inhibitor with an IC50 of 11 μM for rat liver DHODH. DHODH-IN-15 can be used for rheumatoid arthritis .
loading...
    loading...
Cat. No.: HY-135676
CAS No.: 1263303-93-0
DHODH-IN-12 (Compound 12b) is a Leflunomide derivative and a weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07 .
loading...
    loading...
Cat. No.: HY-183925
CAS No.: 52962-95-5
Research Areas:  

Infection

Redoxal is a dihydroorotate dehydrogenase (DHODH) inhibitor and anti-HIV-1 agent. Redoxal induces intracellular pyrimidine depletion by inhibiting the de novo pyrimidine biosynthesis pathway, enhances the protein stability of APOBEC3G (A3G), upregulates the abundance of A3G protein in cells and progeny viral particles, thereby strengthening the host endogenous antiviral restriction mediated by A3G . Redoxal selectively targets DHOdehase at the mitochondrial level, with an IC50 of 430 nM for inhibiting DHO oxidation in human mitochondria and an IC50 of 910 nM in rat mitochondria . Redoxal can be used in studies related to HIV-1 infection .
loading...
    loading...